Both in Biotechnology
Ginkgo Bioworks Holdings vs Aura Biosciences
Over the past year DNA returned −12.9% and AURA returned +7.5%; their daily moves had a correlation of 0.23.
DNA −12.9% AURA +7.5%Growth of $1, one year, split-adjusted
| Metric | DNA | AURA |
|---|---|---|
| Price | $11.15 | $6.50 |
| Market cap | $750.5M | $673.6M |
| Today | +3.58% | +4.09% |
| 1 month | −10.2% | +5.3% |
| 6 months | +10.6% | −21.7% |
| Year to date | +34.1% | +19.2% |
| 1 year | −12.9% | +7.5% |
| Revenue growth (YoY) | −48.5% | — |
| Gross margin | 91.5% | — |
| Net margin | −231.7% | — |
| P/E (TTM) | — | — |
| Price / sales | 6.7× | — |
| Net cash | $302.2M | $323.8M |
| Dividend yield | — | — |
| Volatility (60d) | 128.2% | 41.0% |
| Short % of float | 18.4% | 11.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).